MedTrace Logo

Percutaneous Assisted Approach for Total Hip Replacement and it's Effect on Functional Rehabilitation.

NCT02032017 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2014-01-09

No results posted yet for this study

Summary

The purpose of this study is to investigate whether revalidation following total hip replacement through the percutaneous approach is faster or better than following the anterolateral approach. We assume this would be the case since it is possible to spare a large part of the gluteus medius muscle with the percutaneous approach.

Conditions

  • Total Hip Arthroplasty

Interventions

PROCEDURE

Ceramic on ceramic couple

All patients will get a standard total hip replacement (cementless hydroxyapatite coated cup and a titanium plasmasprayed stem) with a ceramic on ceramic (third generation biolox delta) couple. Preoperative leg length and offset are marked to reconstruct the preoperative leg length and to obtain the optimal offset.

PROCEDURE

Percutaneous assisted approach

PROCEDURE

Anterolateral approach

OTHER

Usual care

Both groups will receive usual care (UC) after surgery. This includes standard physiotherapy care consisting of mobilizing and strengthening techniques. All patients will receive a booklet containing information about the surgery, weight bearing after the surgery, and rehabilitation in general.

Sponsors & Collaborators

  • Stöpler Belgium nv

    collaborator UNKNOWN

  • Universiteit Antwerpen

    lead OTHER

Principal Investigators

  • Claudia Hendrickx, PhD student · Universiteit Antwerpen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2014-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02032017 on ClinicalTrials.gov